BIOGEN INC. — Investor Relations & Filings
Biogen Inc. is a global biotechnology company focused on discovering, developing, and delivering innovative therapies for people with serious neurological and neurodegenerative diseases. Founded in 1978, the company leverages cutting-edge science to address complex and hard-to-treat conditions. Its core therapeutic areas include multiple sclerosis, Alzheimer's disease, spinal muscular atrophy, and amyotrophic lateral sclerosis. In addition to its portfolio of novel drugs, Biogen also develops and commercializes biosimilars. The company's pipeline is concentrated on potential breakthrough treatments in neurology, immunology, and rare diseases, aiming to address significant unmet medical needs and improve patient outcomes worldwide.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-14 | English | |
| Major Shareholding Notification 2026 | 2026-05-06 | English | |
| Major Shareholding Notification 2026 | 2026-04-29 | English | |
| 10-Q - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | |
| 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | |
| ARS | 2026-04-28 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46003499 | 8-K | 2026-05-14 | English | ||
| 46147249 | Major Shareholding Notification 2026 | 2026-05-06 | English | ||
| 46147251 | Major Shareholding Notification 2026 | 2026-04-29 | English | ||
| 38512550 | 10-Q - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | ||
| 38494955 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-29 | English | ||
| 46147256 | ARS | 2026-04-28 | English | ||
| 46147325 | DEFA14A | 2026-04-28 | English | ||
| 46147321 | DEF 14A | 2026-04-28 | English | ||
| 46147329 | Major Shareholding Notification 2026 | 2026-04-07 | English | ||
| 33590958 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-04-06 | English | ||
| 33122713 | 8-K - BIOGEN INC. (0000875045) (Filer) | 2026-03-31 | English | ||
| 33052213 | SCHEDULE 13G/A - BIOGEN INC. (0000875045) (Subject) | 2026-03-26 | English | ||
| 46147335 | CURRENT REPORT | 2026-03-11 | English | ||
| 32882744 | 4 - BIOGEN INC. (0000875045) (Filer) | 2026-02-18 | English | ||
| 32882743 | 4 - BIOGEN INC. (0000875045) (Filer) | 2026-02-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Camurus
Develops and commercializes long-acting medicines for sever…
|
CAMX | SE | Manufacturing |
|
CANbridge Pharmaceuticals Inc.
Global biopharma developing and commercializing transformat…
|
1228 | KY | Manufacturing |
|
Candel Therapeutics, Inc.
Develops viral immunotherapies to activate the immune syste…
|
CADL | US | Manufacturing |
|
Can-Fite BioPharma Ltd.
Clinical-stage biopharma developing oral small-molecule dru…
|
CANF | IL | Manufacturing |
|
Cangene Corporation
Biopharma focused on developing and manufacturing plasma-de…
|
CNJ | CA | Manufacturing |
|
Cannabotech Ltd.
Develops therapies by integrating cannabinoids and medicina…
|
CNTC | IL | Manufacturing |
|
Cannara Biotech Inc.
Large-scale, low-cost producer of premium cannabis products…
|
LOVE | CA | Manufacturing |
|
Cannex Capital Holdings Inc.
Operated across the entire cannabis value chain, producing …
|
CNNX | CA | Manufacturing |
|
CANN GROUP LIMITED
Cultivates, manufactures, and supplies pharmaceutical-grade…
|
CAN | AU | Manufacturing |
|
CanniMed Therapeutics Inc.
Biopharmaceutical producer of standardized, pharmaceutical-…
|
CMED | CA | Manufacturing |
BIOGEN INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30291/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30291 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30291 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30291 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30291}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BIOGEN INC. (id: 30291)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.